258 related articles for article (PubMed ID: 23821515)
1. Quality of life in lung transplantation.
Singer JP; Singer LG
Semin Respir Crit Care Med; 2013 Jun; 34(3):421-30. PubMed ID: 23821515
[TBL] [Abstract][Full Text] [Related]
2. Lung transplantation and bronchiolitis obliterans syndrome: are two lungs better than one?
Levine SM
Chest; 2002 Oct; 122(4):1112-4. PubMed ID: 12377826
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness and quality of life: benefits of lung transplantation.
Singer LG
Respir Care Clin N Am; 2004 Dec; 10(4):449-57, v. PubMed ID: 15585177
[TBL] [Abstract][Full Text] [Related]
4. Determinants of health utility in lung and heart-lung transplant recipients.
Singer LG; Gould MK; Tomlinson G; Theodore J
Am J Transplant; 2005 Jan; 5(1):103-9. PubMed ID: 15636617
[TBL] [Abstract][Full Text] [Related]
5. Long-term health-related quality of life after lung transplantation: different predictors for different dimensions.
Vermuelen KM; van der Bij W; Erasmus ME; TenVergert EM
J Heart Lung Transplant; 2007 Feb; 26(2):188-93. PubMed ID: 17258154
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT.
Amin EN; Phillips GS; Elder P; Jaglowski S; Devine SM; Wood KL
Bone Marrow Transplant; 2015 Feb; 50(2):289-95. PubMed ID: 25419692
[TBL] [Abstract][Full Text] [Related]
7. Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease.
Egan JJ
Am J Respir Crit Care Med; 2004 Nov; 170(9):931-2. PubMed ID: 15504816
[No Abstract] [Full Text] [Related]
8. Long-term quality of life in patients surviving at least 55 months after lung transplantation.
Vermeulen KM; Ouwens JP; van der Bij W; de Boer WJ; Koëter GH; TenVergert EM
Gen Hosp Psychiatry; 2003; 25(2):95-102. PubMed ID: 12676422
[TBL] [Abstract][Full Text] [Related]
9. Transplant bronchiolitis obliterans: Deja vu.
Anthonisen NR
Can Respir J; 2003 Mar; 10(2):66-8. PubMed ID: 12687024
[No Abstract] [Full Text] [Related]
10. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
11. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
[TBL] [Abstract][Full Text] [Related]
12. Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era.
Emaminia A; Hennessy SA; Hranjec T; LaPar DJ; Kozower BD; Jones DR; Kron IL; Lau CL
J Thorac Cardiovasc Surg; 2011 May; 141(5):1278-82. PubMed ID: 21320711
[TBL] [Abstract][Full Text] [Related]
13. The effect of bronchiolitis obliterans syndrome on health related quality of life.
Vermeulen KM; Groen H; van der Bij W; Erasmus ME; Koëter GH; TenVergert EM
Clin Transplant; 2004 Aug; 18(4):377-83. PubMed ID: 15233813
[TBL] [Abstract][Full Text] [Related]
14. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
[TBL] [Abstract][Full Text] [Related]
15. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation.
Kolaitis NA; Soong A; Shrestha P; Zhuo H; Neuhaus J; Katz PP; Greenland JR; Golden J; Leard LE; Shah RJ; Hays SR; Kukreja J; Kleinhenz ME; Blanc PD; Singer JP
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):440-448.e2. PubMed ID: 29550072
[TBL] [Abstract][Full Text] [Related]
16. Intensive pulmonary rehabilitation in a pediatric lung transplantation patient: A case report.
Choi EJ; Kim W; Jeon JY; Ko EJ; Yu J; Choi SH; Lee SH; Sung IY
Medicine (Baltimore); 2021 Apr; 100(17):e25523. PubMed ID: 33907101
[TBL] [Abstract][Full Text] [Related]
17. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
Nørgaard MA; Andersen CB; Pettersson G
Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
[TBL] [Abstract][Full Text] [Related]
18. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.
Cantu E; Appel JZ; Hartwig MG; Woreta H; Green C; Messier R; Palmer SM; Davis RD
Ann Thorac Surg; 2004 Oct; 78(4):1142-51; discussion 1142-51. PubMed ID: 15464462
[TBL] [Abstract][Full Text] [Related]
19. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.
Gerbase MW; Soccal PM; Spiliopoulos A; Nicod LP; Rochat T
J Heart Lung Transplant; 2008 Aug; 27(8):898-904. PubMed ID: 18656804
[TBL] [Abstract][Full Text] [Related]
20. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC
Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
